Effects of Ginkgo biloba on airway histology in a mouse model of chronic asthma

Allergy and Asthma Proceedings

Volumn 30, Issue 2, 2009, Pages 186-191

  Babayigit, Arzu ^a   Olmez, Duygu ^a   Karaman, Ozkan ^a   Ozogul, Candan ^a   Yilmaz, Osman ^a   Kivcak, Bijen ^b   Erbil, Guven ^a   Uzuner, Nevin ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

BALB c mice; Dexamethasone; Electron microscopy; Ginkgo biloba; Histology; Inflammation; Light microscopy; Lung; Mouse model of asthma; Remodeling

Indexed keywords

DEXAMETHASONE; GINKGO BILOBA EXTRACT; OVALBUMIN; SODIUM CHLORIDE; PLANT EXTRACT; THROMBOCYTE ACTIVATING FACTOR;

AIRWAY; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CHRONIC DISEASE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; EXPERIMENTAL MODEL; GOBLET CELL; HISTOPATHOLOGY; LUNG ALVEOLUS EPITHELIUM; MALE; MAST CELL; MOUSE; NONHUMAN; SENSITIZATION; SMOOTH MUSCLE; TREATMENT OUTCOME; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; DISEASE MODEL; DRUG ANTAGONISM; GINKGO BILOBA; IMMUNIZATION; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG; PATHOLOGY; PHYTOTHERAPY; PLANT LEAF; RESPIRATORY TRACT MUCOSA;

ANIMALS; ASTHMA; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; GINKGO BILOBA; IMMUNIZATION, SECONDARY; INJECTIONS, INTRAPERITONEAL; LUNG; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PLATELET ACTIVATING FACTOR; RESPIRATORY MUCOSA;

EID: 67650504658     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2009.30.3187     Document Type: Article

References (33)

1. Rabe KF, Adachi M, Lai CKW, et al. Worldwide severity and control of asthma in children and adults: The global asthma insights and reality surveys. J Allergy Clin Immunol 114:40-47, 2004.
2. Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patient. Chest 113:578-592, 1998.
3. Chan PW, and DeBruyne JA. Parental concern towards the use of inhaled therapy in children with chronic asthma. Pediatr Int 42:547-551, 2000.
4. Bender B, Bartlett S, Rand C, et al. Objective measurement of adherence with asthma medications. J Allergy Clin Immunol 117:S265, 2006.
5. Ernst E. Complementary therapies for asthma: What patients use? J Asthma 35:667-671, 1998.
6. Huntley A, Ernst E. Herbal medicines for asthma: A systematic review. Thorax 55:925-929, 2000.
7. Blanc PD, Trupin L, Earnest G, et al. Alternative therapies among adults with a reported diagnosis of asthma or rhinosinusitis: Data from a population-based survey. Chest 120:1461-1467, 2001.
8. Ammon HP, Mack T, Singh GB, et al. Inhibition of LTB4-formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin extract of Boswellia serrata. Planta Med 57:203-207, 1991.
9. Chan PC, Xia Q, and Fu PP. Ginkgo biloba leave extract: Biological, medicinal, and toxicological effects. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 25:211-244, 2007.
10. Mauri P, Migliazza B, and Pietta P. Liquid chromatography/electrospray mass spectrometry of bioactive terpenoids in Ginkgo biloba L. J Mass Spectrom 34:1361-1367, 1999.
11. Xia SH, and Fang DC. Pharmacological action and mechanisms of ginkgolide B. Chin Med J (Engl) 120:922-928, 2007.
12. Mahmoud FF, Haines DD, Abul HT, et al. In vitro effects of astaxanthin combined with ginkgolide B on T lymphocyte activation in peripheral blood mononuclear cells from asthmatic subjects. J Pharmacol Sci 94:129-136, 2004.
13. Temelkovski J, Hogan SP, Shepherd DP, et al. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 53:849-856, 1998.
14. Babayigit A, Olmez D, Karaman O, et al. Ginseng ameliorates chronic histopathologic changes in a murine model of asthma. Allergy Asthma Proc 29:493-498, 2008.
15. Hansel TT, and Barnes PJ. Novel drugs for treating asthma. Curr Allergy Asthma Rep 1:164-173, 2001.
16. Walsh GM. Targeting airway inflammation: Novel therapies for the treatment of asthma. Curr Med Chem 13:3105-3111, 2006.
17. Kumar RK. Understanding airway wall remodeling in asthma: A basis for improvements in therapy? Pharmacol Ther 91:93-104, 2001.
18. Frieri M. Advances in the understanding of allergic asthma. Allergy Asthma Proc 28:614-619, 2007.
19. Lloyd CM, and Robinson DS. Allergen-induced airway remodeling. Eur Respir J 29:1020-1032, 2007.
20. Tagaya E, and Tamaoki J. Mechanisms of airway remodeling in asthma. Allergol Int 56:331-340, 2007.
21. Payne DN, Rogers AV, Adelroth E, et al. Early thickening of the reticular basement in children with difficult asthma. Am J Respir Crit Care Med 167:78-82, 2003.
22. Barnes PJ, Chung KF, and Page CP. Inflammatory mediators of asthma: An update. Pharmacol Rev 50:515-596, 1998.
23. Kay AB. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma. Eur J Respir Dis Suppl 129:1-44, 1983.
24. Kasperska-Zajac A, Brzoza Z, and Rogala B. Platelet activating factor as a mediator and therapeutic approach in bronchial asthma. Inflammation 31:112-120, 2008.
25. Hsieh KH. Effects of PAF antagonist, BN52021, on the PAF, methacholine, and allergen-induced bronchoconstriction in asthmatic children. Chest 99:877-882, 1991.
26. Kishimoto S, Shimadzu W, Izumi T, et al. Comparison of platelet-activating factor receptor mRNA levels in peripheral blood eosinophils from normal subjects and atopic asthmatic patients. Int Arch Allergy Immunol 114(suppl):60-63, 1997.
27. Schauer U, Koch B, Michl U, et al. Enhanced production of platelet activating factor by peripheral granulocytes from children with asthma. Allergy 47:143-149, 1992.
28. Tang Y, Xu Y, Xiong S, et al. The effect of Ginkgo Biloba extract on the expression of PKCalpha in the inflammatory cells and the level of IL-5 in induced sputum of asthmatic patients. J Huazhong Univ Sci Technolog Med Sci 27:375-380, 2007 (Abs).
29. Sierpina VS, Wollschlaeger B, and Blumenthal M. Ginkgo biloba. Am Fam Physician 1:68:923-926, 2003.
30. Kleijnen J, and Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 34:352-358, 1992.
31. Rowin J, and Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 46:1775-1776, 1996.
32. Vale S. Subarachnoid hemorrhage associated with Ginkgo biloba. Lancet 352:36, 1998.
33. Matthews MK Jr. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 50:1933-1934, 1998.